The Effect of Electrostimulation and Compression Applications on Neuropathy Symptoms and Quality of Life in the Management of Chemotherapy-Induced Peripheral Neuropathy in Gastrointestinal System Cancer Patients Receiving Oxaliplatin-Based Treatment

Data collection was carried out using the "Patient Demographic Form," the National Cancer Institute CTCAE v5.0 toxicity criteria, the EORTC QLQ-C30 General Quality of Life Scale, the EORTC QLQ-CIPN20 Chemotherapy-Induced Neuropathy Scale, and the Neuropathic Pain Assessment Scale (DN4). The measurement tools used in the study were administered a total of six times (in each cycle): "initial follow-up (2nd cycle, before intervention), 3rd cycle, 4th cycle, 5th cycle, 6th cycle, and 6th month." As a result of the interventions applied to the patients, statistically significant differences were found between the TENS, TENS+Compression, and Compression intervention groups compared to the Control group in terms of General Quality of Life, severity and number of symptoms due to peripheral neuropathy, and pain level (p\<0.05). In conclusion, it can be said that TENS and Compression applications positively contribute to pain, symptom severity, and symptom number caused by peripheral neuropathy in gastrointestinal cancer patients who developed peripheral neuropathy due to oxaliplatin.